Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.
OBJECTIVE: Assessment of the safety and efficacy of a 10-day melarsoprol schedule in second stage T.b. rhodesiense patients and the effect of suramin-pretreatment on the incidence of encephalopathic syndrome (ES) during melarsoprol therapy. DESIGN: Sequential conduct of a proof-of-concept trial (n =...
Main Authors: | Irene Kuepfer, Caecilia Schmid, Mpairwe Allan, Andrew Edielu, Emma P Haary, Abbas Kakembo, Stafford Kibona, Johannes Blum, Christian Burri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-08-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3435133?pdf=render |
Similar Items
-
Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.
by: Irene Kuepfer, et al.
Published: (2011-01-01) -
Trypanososma brucei rhodesiense Sleeping Sickness, Uganda
by: Lea Berrang-Ford, et al.
Published: (2012-10-01) -
Quantifying the burden of rhodesiense sleeping sickness in Urambo District, Tanzania.
by: Lucas E Matemba, et al.
Published: (2010-01-01) -
High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo
by: Jo Robays, et al.
Published: (2008-06-01) -
Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association
by: Jorge Seixas, et al.
Published: (2020-01-01)